No Data
Hong Kong stocks movement | CHUNLI MEDICAL (01858) is currently up over 7%. The company's Overseas Business revenue has increased by 78% year-on-year, and the domestic Business is expected to gradually recover from the impact of centralized procurement.
CHUNLI MEDICAL (01858) is currently up over 7%, as of the time of publishing, up 6.42%, priced at HKD 9.95, with a trading volume of HKD 12.499 million.
2024 Annual Report
2024 Annual Report Summary
CHUNLI MEDICAL (01858) announced its performance for 2024, with a net profit attributable to the parent company of approximately 0.125 billion yuan, a year-on-year decrease of about 55%.
CHUNLI MEDICAL (01858) announced its 2024 performance, with revenue of approximately 0.806 billion yuan, a year-on-year decrease of 33.3...
CHUNLI MEDICAL: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2024
CHUNLI MEDICAL (01858.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui reported on March 18 that CHUNLI MEDICAL (01858.HK) announced that a Board of Directors meeting will be held on March 28, 2025 (Friday), for the purpose of approving the annual performance announcement for the fiscal year ending December 31, 2024, and considering the payment of a final dividend (if any).
